Vir Biotechnology is a clinical-stage biopharmaceutical company that combines immunologic insights with advanced technologies to develop innovative treatments for serious infectious diseases and cancer. By leveraging four distinct technology platforms, Vir is dedicated to transforming lives through its extensive portfolio that includes both clinical and preclinical programs.
